Placental Pathology and Inflammatory Factor Analysis of OAPS
NCT05378516 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2022-05-18
Summary
This investigation is on placental pathological changes and inflammatory factors associated with obstetric antiphospholipid syndrome.
Conditions
- Antiphospholipid Syndrome in Pregnancy
Interventions
- OTHER
-
no intervention
no intervention
Sponsors & Collaborators
-
Peking University People's Hospital
lead OTHER
Principal Investigators
-
Jingjing Yang, doctor · Peking University People's Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2022-05-12
- Completion
- 2023-12-31
Countries
- China
Study Locations
More Related Trials
-
Inflammatory Biomarkers for the Diagnosis of oPRES
NCT05433870 ·Status: COMPLETED
-
Plasma Concentration of Biological Markers in Placental Abruption
NCT03782168 ·Status: TERMINATED
-
Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
NCT05679206 ·Status: RECRUITING
-
Screening for Intrapartum Fetal Compromise Using Placental Biomarkers
NCT07258329 ·Status: RECRUITING
-
Study of Placental Function in Healthy and Pathological Pregnancies
NCT02321007 ·Status: RECRUITING
-
Effect of Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A Possible Role of Hypoxia Inducible Factor-1α.
NCT05158868 ·Status: UNKNOWN
-
Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
NCT00180817 ·Status: COMPLETED
-
Establish the Referenc Range of Antiphospholipid Antibody in Healthy Preganany Women
NCT05883189 ·Status: UNKNOWN
-
Antiphospholipid Antibodies and Fetal Growth Restriction
NCT01538134 ·Status: UNKNOWN
-
Clinical Features, Outcomes, and Therapeutics of Pregnancy-Related Aortic Dissection
NCT05501145 ·Status: COMPLETED
-
The Mechanism of Adverse Pregnancy Outcomes Influenced by Maternal Air Pollution Exposure
NCT04215406 ·Status: UNKNOWN
-
Study on Retroplacental Hematomas in Finistère
NCT04168606 ·Status: COMPLETED
-
Medium-term Follow-up of Patients With Obstetric Antiphospholipid Syndrome: MRI Study of White Matter
NCT03600636 ·Status: COMPLETED ·Phase: NA
-
China Obstetrics Alliance Cohort Study
NCT03038555 ·Status: UNKNOWN
-
Negative Antiphospholipid Syndrome: a Multicentric Study
NCT06373003 ·Status: RECRUITING
-
The Clinical and Prognostic Features of PRES
NCT05143710 ·Status: COMPLETED
-
Autophagy/Apoptosis Balance in Placental Vascular Pathologies
NCT06779916 ·Status: RECRUITING
-
Placental Growth and Adverse Pregnancy Outcomes
NCT01669525 ·Status: COMPLETED
-
Effects of Recurrent PE on Women and Offspring
NCT05134285 ·Status: UNKNOWN
-
The Expression of Aquaporin 3, 8 and 9 in Placenta in Normal and Preeclamptic Pregnancies: Perinatal and Neonatal Outcomes.
NCT02045316 ·Status: UNKNOWN
-
Antiphospholipid Antibodies and Early Severe Preeclampsia.
NCT01538121 ·Status: UNKNOWN
-
Impact of Pelvic Floor Musculature on Peripartum Outcomes
NCT01208246 ·Status: COMPLETED
-
Role of Vaspin in Pathophysiology of Pre-eclampsia
NCT06437535 ·Status: NOT_YET_RECRUITING
-
Symptoms and Function During and After Pregnancy
NCT01787266 ·Status: COMPLETED
-
The Placenta Previa and Fetal Weight
NCT03321435 ·Status: COMPLETED